Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Aveanna Healthcare Holdings Inc. (AVAH) Financial Statements

Aveanna Healthcare Holdings Inc. (AVAH) reported trailing twelve-month revenue of $2.6B (up 19.5% year on year) and net income of $274.8M as of 2026-07-04, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $158.4M.

Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason

AVAHAveanna Healthcare Holdings Inc.Follow AVAH — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
2.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jul 26.

LineFY2019
Dec 19
FY2020
Jan 21
FY2021
Jan 22
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Jan 26
TTM
Jul 26
Trend
Revenue1.381.501.681.791.902.022.432.60
Gross profit0.420.450.540.550.600.640.810.84
Operating income0.04-0.00-0.04-0.640.010.140.260.27
Pre-tax income-0.08-0.05-0.11-0.66-0.140.010.110.15
Income tax0.000.010.00-0.00-0.000.02-0.12-0.12
Net income-0.08-0.06-0.12-0.66-0.13-0.010.230.27
Diluted EPS ($)-0.56-0.40-0.69-3.57-0.71-0.061.051.26
Diluted shares (bn)———0.1860.1900.1930.215—

USD billions · SEC XBRL

Aveanna Healthcare Holdings Inc. — questions

What is Aveanna Healthcare Holdings Inc.'s revenue?
$2.6B over the twelve months to 2026-07-04, up 19.5% year on year, from its 10-Q and 10-K filings.
What is Aveanna Healthcare Holdings Inc.'s net income?
$274.8M over the twelve months to 2026-07-04.
What is Aveanna Healthcare Holdings Inc.'s free cash flow?
$158.4M over the twelve months to 2026-07-04.
What are Aveanna Healthcare Holdings Inc.'s diluted earnings per share?
$1.26 over the twelve months to 2026-07-04.

Every figure on this page comes from Aveanna Healthcare Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.